Free Trial

Quilter Plc Increases Holdings in Zoetis Inc. (NYSE:ZTS)

Zoetis logo with Medical background

Quilter Plc increased its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 6.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 375,828 shares of the company's stock after buying an additional 22,154 shares during the period. Quilter Plc owned 0.08% of Zoetis worth $61,880,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ZTS. Brighton Jones LLC boosted its stake in Zoetis by 180.4% during the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock valued at $754,000 after purchasing an additional 2,978 shares during the last quarter. Bank Pictet & Cie Europe AG lifted its stake in Zoetis by 5.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 419,530 shares of the company's stock valued at $68,354,000 after acquiring an additional 21,470 shares in the last quarter. Sigma Planning Corp grew its stake in shares of Zoetis by 4.3% in the 4th quarter. Sigma Planning Corp now owns 3,367 shares of the company's stock worth $549,000 after acquiring an additional 140 shares in the last quarter. IFP Advisors Inc raised its holdings in shares of Zoetis by 13.0% in the fourth quarter. IFP Advisors Inc now owns 10,033 shares of the company's stock valued at $1,635,000 after purchasing an additional 1,158 shares during the last quarter. Finally, Lake Street Advisors Group LLC raised its holdings in shares of Zoetis by 3.1% in the fourth quarter. Lake Street Advisors Group LLC now owns 11,186 shares of the company's stock valued at $1,823,000 after purchasing an additional 341 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of the stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total transaction of $110,840.00. Following the transaction, the executive vice president now owns 15,129 shares in the company, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.16% of the stock is owned by company insiders.

Zoetis Stock Performance

Shares of NYSE ZTS traded down $0.31 during mid-day trading on Monday, hitting $155.86. The company had a trading volume of 2,803,765 shares, compared to its average volume of 2,561,144. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12. Zoetis Inc. has a 1 year low of $139.70 and a 1 year high of $200.33. The company has a market capitalization of $69.39 billion, a price-to-earnings ratio of 27.98, a P/E/G ratio of 2.59 and a beta of 0.94. The stock's 50-day moving average price is $160.40 and its 200-day moving average price is $162.52.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. The business had revenue of $2.22 billion during the quarter, compared to analysts' expectations of $2.20 billion. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The firm's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.38 EPS. On average, sell-side analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.28%. Zoetis's payout ratio is 35.91%.

Analyst Ratings Changes

ZTS has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of Zoetis from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Stifel Nicolaus lowered Zoetis from a "buy" rating to a "hold" rating and reduced their price target for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Piper Sandler boosted their price target on shares of Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a research report on Monday, May 12th. Finally, UBS Group cut their price objective on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a report on Wednesday, May 7th. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, Zoetis has a consensus rating of "Buy" and an average price target of $212.13.

Check Out Our Latest Stock Analysis on ZTS

About Zoetis

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

See Also

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Should You Invest $1,000 in Zoetis Right Now?

Before you consider Zoetis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.

While Zoetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines